Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers

Psychopharmacology

Volumn 143, Issue 1, 1999, Pages 24-28

  Bonne, Omer ^a   Krausz, Yodphat ^a   Aharon, Yitzhak ^a   Gelfin, Yevgenia ^b   Chisin, Roland ^a   Lerer, Bernard ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Clinical Research Center for Brain Sciences   (Israel)

Author keywords

Cerebral blood flow; Fluoxetine; HMPAO SPECT; Mental disorder; Normal control

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CORRELATION FUNCTION; DEPRESSION; DRUG EFFECT; FEMALE; HUMAN; MALE; MENTAL DISEASE; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; FEMALE; FLUOXETINE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SINGLE-BLIND METHOD; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032947545     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050915     Document Type: Article

References (39)

1. Baxter LR, Schwartz JM, Phelps ME, Maziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM (1989) Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243-250
2. Bench CJ, Frackowiak RSJ, Dolan RJ (1995) Changes in regional cerebral blood flow on recovery from depression. Psychol Med 25:247-261
3. Bonne O, Krausz Y, Gorfine M, Shapira B, Bocher M, Karger H, Chisin R, Lerer B (1996a) Cerebral blood flow in depressed patients before and after treatment with electroconvulsive therapy. J Nucl Med 37:1075-1080
4. Bonne O, Krausz Y, Gorfine M, Karger H, Gelfin Y, Shapira B, Chishin R, Lerer B (1996b) Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. J Affect Disord 41:163-171
5. Bremner DJ, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS (1997) Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54:364-374
6. Briley M, Moret C (1993) Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 5:387-400
7. Cook EH Jr, Metz J, Cooper MD, Chou JS, Leventhal BL (1992) Fenfluramine and cerebral glucose [letter]. Biol Psychiatry 31:1173-1174
8. Cook EH, Metz J, Leventhal B, Lebovitz M, Nathan M, Semerdjian SA, Brown T, Cooper MD (1994) Fluoxetine effects on cerebral glucose metabolism. Neuro Report 5:1745-1748
9. De-Micheli E, Soncrant TT (1992) Age-dependent cerebral metabolic effects of unilateral nucleus basalis magnocellularis ablation in rats. Neurobiol Aging 13:687-695
10. Di Mascio A, Heninger G, Klerman GL (1964) Psychopharmacology of imipramine and desipramine: a comparative study of their effects in normal males. Psychopharmacolgia 5:361-371
11. Freo U (1996) Cerebral metabolic effects of serotonin drugs and neurotoxins. Life Sci 59:877-891
12. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS (1990) The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 10:458-466
13. Friston KJ, Frith CD, Liddle PF, Frackowiak RS (1991) Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 11:690-699
14. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CB, Frackowiak RSJ (1995a) Statistical parametric maps in functional imaging. A general approach. Hum Brain Map 2:189-210
15. Friston KJ, Ashburner J, Poline JB, Frith CB, Heather JD, Frackowiak RSJ (1995b) Spatial realignment and normalization of images. Hum Brain Map 2:165-189
16. Gelfin Y, Gorfine M, Lerer B (1998) Effect of clinically equivalent fluoxetine administration on mood and other psychological parameters in healthy volunteers. Am J Psychiatry 155: 290-292
17. Goodwin GM, Austin MP, Dougall N, Ross M, Murray C, O'Carroll RE, Moffoot A, Prentice N, Ebmeir KP (1993) State changes in brain activity shown by the uptake of 99m-Tc exametazine with single photon emission tomography in major depression before and after treatment. J Affect Disord 29:245-255
18. 1A partial agonist buspirone on regional cerebral blood flow in man. Psychopharmacology 108:380-386
19. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
20. Kanaya T, Yonekawa M (1990) Regional cerebral blood flow in depression. Jpn J Psychiatr Neurol 44:571-576
21. Kapur S, Meyer J, Wilson AA, Houle S, Brown FM (1994) Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans. Brain Res 646:292-294
22. Kasper S, Fuger J, Moller HJ (1992) Comparative efficacy of antidepressants drugs. Drugs 43 [Suppl 2]:11-23
23. Kramer PD (1993) Listening to Prozac. Penguin Group New York, New York
24. Krausz Y, Bonne O, Karger H, Gorfine M, Gelfin Y, Lerer B, Chishin R (1998) Age-related changes in brain perfusion of normal subjects detected by 99m Tc-HMPAO SPECT. Neuroradiology 40:428-434
25. Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA (1996) Positron emission tomogra-phic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. J Cereb Blood Flow Metab 16:418-426
26. Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, Pappata S, Syrota A (1990) Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 147:1313-1317
27. 2O PET study in humans. Neurosci Lett 207:25-28
28. Molina V, Montz R, Martin-Loeches M, Jimenez-Vicioso A, Carreras JL, Rubia FJ (1995) Drug therapy and cerebral perfusion in obsessive-compulsive disorder. J Nucl Med 36:2234-2238
29. Parsons AA (1991) 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci 12:310-315
30. Passero S, Nardini M, Battisini N (1995) Regional cerebral blood changes following chronic administration of antidepressant drugs. Prog Neuropsychopharmacol Biol Psychiatry 19: 627-636
31. 18F]FDGPET study in obsessive-compulsive disorder. Br J Psychiatry 166:244-250
32. Poldinger W (1963) Comparison between imipramine and desipramine in normal subjects and their action in depressive patients. Psychopharmacologia 4:302-307
33. Rubin RT, Villanueva-Meyer J, Ananth J, Trajmar PG, Mena I (1992) Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Arch Gen Psychiatry 49:695-702
34. Rubin RT, Ananth J, Villanueva-Meyer J, Trajmar PG, Mena I (1995) Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry 38:429-437
35. Sokoloff L (1981) Relationships among local functional acitivity, energy metabolism and blood flow in the central nervous system. Fed Proc 40:2311-2314
36. Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J (1993) Selective serotonin reuptake inhibitors: metaanalysis of efficacy and acceptability BMJ 306:683-687
37. Spitzer RL, Endicott J (1978) Schedule for affective disorders and schizophrenia - lifetime version (SADS-L). New York Psychiatric Institute, New York
38. Syed GMS, Eagger S, Toone BK, Levy R, Barrett JJ (1992) Quantification of regional cerebral blood flow (rCBF) using Tc-99m-HMPAO and SPECT: choice of the reference region. Nucl Med Commun 13:811-816
39. Talairach J, Zilkha G, Tournoux P, Prosalentis A, Bordas-Ferrier M, Covello L, Iacob M, Mempel E (1988) Atlas d'Anatomie Stereotatactique du Telencephale. Masson, Paris